Assessing biomarker use in risk assessment - A survey of practitioners

Journal of Toxicology and Environmental Health - Part A

Volumn 67, Issue 8-10, 2004, Pages 687-695

  Maier, Andrew ^a   Savage Jr , Russell E ^b   Haber, Lynne T ^a  

^a Toxicology Excellence for Risk Assessment   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANALYTIC METHOD; CONFERENCE PAPER; DOSE RESPONSE; EXPOSURE; HEALTH HAZARD; HUMAN; MEASUREMENT; PHYSICIAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HAZARDOUS SUBSTANCES; HUMANS; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 1942532008     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287390490428161     Document Type: Conference Paper

References (14)

1. American Conference Governmental Industrial Hygienists. 2001. Documentation of the threshold limit values and biological exposure indices, 7th ed. Cincinnati, OH: ACGIH.
2. Dourson, M. L., Teuschler, L. K., Durkin, P. R., and Stiteler, W. M. 1997. Categorical regression of toxicity data: A case study using aldicarb. Regul. Toxicol. Pharmacol. 25:121-129.
3. Gentry, P. R., Hack, C. E., Haber, L., Maier, A., and Clewell, H. J. III. 2002. An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicol. Sci. 70:120-139.
4. Haber, L. T., Maier, A., Zhao, Q., Dollarhide, J., Savage, R. E., Jr., and Dourson, M. L. 2001. Applications of mechanistic data in risk assessment: The past, present and future. Toxicol. Sci. 61:32-39.
5. Haber, L. T., Maier, A., Gentry, P. R., Clewell, H. J., and Dourson, M. L. 2002. Genetic polymorphisms in assessing interindividual variability in delivered dose. Regul. Toxicol. Pharmacol. 35:177-197.
6. International Program on Chemical Safety. 2001. Guidance document for the use of data in development of chemical-specific adjustment factors (CSAF) for interspecies differences and human variability in dose/concentration response assessment. Geneva: IPCS, World Health Organization.
7. National Research Council. 1987. Biological markers in environmental health research. Environ. Health Perspect. 74:1-191.
8. Perera, F. P. 2000. Molecular epidemiology: On the path to prevention? JNCI 92:602-611.
9. Perera, F. P., and Weinstein, I. B. 1982. Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causation. J. Chron. Dis. 35:581-600.
10. Rodricks, J. V. 2000. Charge to the breakout groups. Using Biomarkers in Human Health Assessment: A Workshop to Identify Research Priorities, 21 June, Raleigh-Durham, NC.
11. Schulte, P. 1989. A conceptual framework for the validation and use of biologic markers. Environ. Res. 48:129-144.
12. Teuschler, L. K., Dourson, M. L., Stiteler, W. M., McClure, P., and Tully, H. 1999. Health risk above the reference dose for multiple chemicals. Regul. Toxicol. Pharmacol. 30:S19-S26.
13. U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/600/8-90/066F. Research Triangle Park, NC: National Center for Environmental Assessment, Office of Research and Development, U.S. EPA.
14. U.S. Environmental Protection Agency. 1999. Draft guidelines for carcinogen risk assessment. NCEA-F-0644. Washington, DC: Risk Assessment Forum, U.S. EPA.